Pneumonia Research Today is a free monthly online journal that collates and summarizes the latest research about Pneumonia, including details on symptoms, viral, bacterial, treatment, causes, walking pneumonia.

Volume 4 (2007), Issue 4 (April)

1. Vitamin and micronutrient intake and the risk of community-acquired pneumonia in US women.
   Am J Med, 120(4): 330-6. [Abstract] [Full-text]
2. Influence of comorbid conditions on long-term mortality after pneumonia in older people.
   J Am Geriatr Soc, 55(4): 518-25. [Abstract] [Full-text]
3. Staphylococcus aureus exploits cathelicidin antimicrobial peptides produced during early pneumonia to promote staphylokinase-dependent fibrinolysis.
   J Infect Dis, 195(9): 1365-72. [Abstract] [Full-text]
4. Reducing neonatal nosocomial bloodstream infections through participation in a national surveillance system.
   J Hosp Infect, 65(4): 319-25. [Abstract] [Full-text]
5. Inadequate treatment of ventilator-associated pneumonia: risk factors and impact on outcomes.
   J Hosp Infect, 65(4): 361-7. [Abstract] [Full-text]
6. Humidification policies for mechanically ventilated intensive care patients and prevention of ventilator-associated pneumonia: a systematic review of randomized controlled trials.
   J Hosp Infect, 65(4): 285-91. [Abstract] [Full-text]
7. Economic evaluation of adherence to treatment guidelines in nonintensive care pneumonia.
   Eur Respir J, 29(4): 751-6. [Abstract] [Full-text]
8. Complete blindness after optic neuropathy induced by short-term linezolid treatment in a patient suffering from muscle dystrophy.
   Pharmacoepidemiol Drug Saf, 16(4): 402-4. [Abstract] [Full-text]
9. Sivelestat reduces reperfusion injury of lungs harvested from endotoxin-primed rats by inhibition of neutrophil-mediated inflammation.
   J Heart Lung Transplant, 26(4): 370-5. [Abstract] [Full-text]
10. Levitronix ventricular assist devices as a bridge to recovery after profound biventricular heart failure associated with pulmonary aspergillosis.
    J Heart Lung Transplant, 26(4): 345-9. [Abstract] [Full-text]
11. Barriers to optimal antibiotic use for community-acquired pneumonia at hospitals: a qualitative study.
    Qual Saf Health Care, 16(2): 143-9. [Abstract] [Full-text]
12. An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients: interhuman transmission or a common environmental source?
    Clin Infect Dis, 44(9): 1143-9. [Abstract] [Full-text]
13. Inflammation-associated remodelling and fibrosis in the lung - a process and an end point.
    Int J Exp Pathol, 88(2): 103-10. [Abstract] [Full-text]
14. Regulation of systemic and local neutrophil responses by G-CSF during pulmonary Pseudomonas aeruginosa infection.
    Blood, 109(8): 3235-43. [Abstract] [Full-text]
15. Leptospiral pneumonias.
    Curr Opin Pulm Med, 13(3): 230-5. [Abstract] [Full-text]
16. Aspiration pneumonias: under-diagnosed and under-treated.
    Curr Opin Pulm Med, 13(3): 192-8. [Abstract] [Full-text]
17. Diagnostic strategies for nosocomial pneumonia.
    Curr Opin Pulm Med, 13(3): 186-91. [Abstract] [Full-text]
18. Community-acquired pneumonia: what is relevant and what is not?
    Curr Opin Pulm Med, 13(3): 177-85. [Abstract] [Full-text]
19. Community acquired pneumonia in the tropics.
    Curr Opin Pulm Med, 13(3): 170-6. [Abstract] [Full-text]
20. Radiological imaging in pneumonia: recent innovations.
    Curr Opin Pulm Med, 13(3): 159-69. [Abstract] [Full-text]
21. Improving management of patients with acute cough by C-reactive protein point of care testing and communication training (IMPAC3T): study protocol of a cluster randomised controlled trial.
    BMC Fam Pract, 8: 15. [Abstract] [Full-text]
22. 100 years of respiratory medicine: pneumonia.
    Respir Med, 101(5): 875-81. [Abstract] [Full-text]
23. Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis.
    Crit Care Med, 35(4): 1061-7. [Abstract] [Full-text]
24. Acute phase markers for the differentiation of infectious and malignant pleural effusions.
    Respir Med, 101(5): 910-8. [Abstract] [Full-text]
25. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis.
    Lancet, 369(9568): 1179-86. [Abstract] [Full-text]
26. Gamma-glutamyltransferase activity and total antioxidant status in serum and platelets of patients with community-acquired pneumonia.
    Arch Med Res, 38(4): 424-31. [Abstract] [Full-text]
27. Polyamine-mediated apoptosis of alveolar macrophages during Pneumocystis pneumonia.
    J Biol Chem, 282(15): 11009-20. [Abstract] [Full-text]
28. Protective and immunomodulatory effect of Gingyo-san in a murine model of acute lung inflammation.
    J Ethnopharmacol, 111(2): 418-26. [Abstract] [Full-text]
29. Does this patient have ventilator-associated pneumonia?
    JAMA, 297(14): 1583-93. [Abstract] [Full-text]
30. Recent advances in community-acquired pneumonia: inpatient and outpatient.
    Chest, 131(4): 1205-15. [Abstract] [Full-text]
31. Serum indicators for the diagnosis of pneumocystis pneumonia.
    Chest, 131(4): 1173-80. [Abstract] [Full-text]
32. Using patient-collected clinical samples and sera to detect and quantify the severe acute respiratory syndrome coronavirus (SARS-CoV).
    Virol J, 4: 32. [Abstract] [Full-text]
33. Patterns and dynamics of airway colonisation in mechanically-ventilated patients.
    Clin Microbiol Infect, 13(5): 476-80. [Abstract] [Full-text]
34. Does invasive diagnosis of nosocomial pneumonia during off-hours delay treatment?
    Intensive Care Med, 33(4): 734-7. [Abstract] [Full-text]
35. Toll-like receptor 2 does not contribute to host response during postinfluenza pneumococcal pneumonia.
    Am J Respir Cell Mol Biol, 36(5): 609-14. [Abstract] [Full-text]
36. Multicenter treatment and outcome evaluation of aspiration syndromes in critically ill patients.
    Ann Pharmacother, 41(4): 549-55. [Abstract] [Full-text]
37. Organizing pneumonia and pulmonary eosinophilic infiltration associated with daptomycin.
    Ann Pharmacother, 41(4): 696-701. [Abstract] [Full-text]
38. Accelerated mortality from hydrocephalus and pneumonia in mice with a combined deficiency of SPAG6 and SPAG16L reveals a functional interrelationship between the two central apparatus proteins.
    Cell Motil Cytoskeleton, 64(5): 360-76. [Abstract] [Full-text]
39. Granulocyte-colony stimulating factor (G-CSF) as an adjunct to antibiotics in the treatment of pneumonia in adults.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
40. Recombinant human activated protein C inhibits local and systemic activation of coagulation without influencing inflammation during Pseudomonas aeruginosa pneumonia in rats.
    Crit Care Med, 35(5): 1362-8. [Abstract] [Full-text]
41. Th1 and Th2 cells are required for both eosinophil- and neutrophil-associated airway inflammatory responses in mice.
    Biochem Biophys Res Commun, 357(1): 44-9. [Abstract] [Full-text]
42. Importance of phosphoinositide 3-kinase gamma in the host defense against pneumococcal infection.
    Am J Respir Crit Care Med, 175(9): 958-66. [Abstract] [Full-text]
43. Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation.
    Am J Respir Crit Care Med, 175(9): 935-42. [Abstract] [Full-text]
44. Antibiotic treatment of community acquired pneumonia varies widely across Germany.
    J Infect, 54(5): 446-53. [Abstract] [Full-text]
45. Reduced computed tomography radiation dose in HIV-related pneumonia: effect on diagnostic image quality.
    Clin Imaging, 31(3): 178-84. [Abstract] [Full-text]
46. Who gets hospitalized for influenza pneumonia in Thailand? Implications for vaccine policy.
    Vaccine, 25(19): 3827-33. [Abstract] [Full-text]
47. Roxithromycin favorably modifies the initial phase of resistance against infection with macrolide-resistant Streptococcus pneumoniae in a murine pneumonia model.
    Antimicrob Agents Chemother, 51(5): 1741-52. [Abstract] [Full-text]
48. Children with pneumonia: how do they present and how are they managed?
    Arch Dis Child, 92(5): 394-8. [Abstract] [Full-text]
49. Incidence of aspiration pneumonia in ALS in Olmsted County, MN.
    Amyotroph Lateral Scler, 8(2): 87-9. [Abstract] [Full-text]
50. A simple screening tool for identification of community-acquired pneumonia in an inner city emergency department.
    Emerg Med J, 24(5): 336-8. [Abstract] [Full-text]
51. Identification of 90% of patients ultimately diagnosed with community-acquired pneumonia within four hours of emergency department arrival may not be feasible.
    Ann Emerg Med, 49(5): 553-9. [Abstract] [Full-text]
52. Brain trauma leads to enhanced lung inflammation and injury: evidence for role of P4504Fs in resolution.
    J Cereb Blood Flow Metab, 27(5): 963-74. [Abstract] [Full-text]
53. Cutoff value of lipid-laden alveolar macrophages for diagnosing aspiration in infants and children.
    Pediatr Pulmonol, 42(5): 452-7. [Abstract] [Full-text]
54. T1/ST2 expression on Th2 cells negatively regulates allergic pulmonary inflammation.
    Eur J Immunol, 37(5): 1302-12. [Abstract] [Full-text]
55. Pulmonary disease due to aspiration of food and other particulate matter: a clinicopathologic study of 59 cases diagnosed on biopsy or resection specimens.
    Am J Surg Pathol, 31(5): 752-9. [Abstract] [Full-text]
56. Infections in the elderly.
    Clin Geriatr Med, 23(2): 441-56, viii. [Abstract] [Full-text]
57. Methicillin-resistant Staphylococcus aureus pneumonia after thoracic surgery: successful treatment with linezolid after failed vancomycin therapy.
    Ann Thorac Surg, 83(5): 1888-91. [Abstract] [Full-text]
58. Oral decontamination for prevention of pneumonia in mechanically ventilated adults: systematic review and meta-analysis.
    BMJ, 334(7599): 889. [Abstract] [Full-text]
59. A population-based assessment of the disease burden of consolidated pneumonia in hospitalized children under five years of age.
    Int J Infect Dis, 11(3): 273-7. [Abstract] [Full-text]
60. Detection of pulmonary Mycoplasma pneumoniae infections in HIV-infected subjects using culture and serology.
    Int J Infect Dis, 11(3): 232-8. [Abstract] [Full-text]
61. Case management of childhood pneumonia in developing countries.
    Pediatr Infect Dis J, 26(5): 432-40. [Abstract] [Full-text]
62. High pneumococcal DNA loads are associated with mortality in Malawian children with invasive pneumococcal disease.
    Pediatr Infect Dis J, 26(5): 416-22. [Abstract] [Full-text]
63. Effect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study.
    Lancet, 369(9571): 1440-51. [Abstract] [Full-text]

© 2004-2008 Pneumonia Research Today. All Rights Reserved.